Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Jung is active.

Publication


Featured researches published by Michael Jung.


Gastrointestinal Endoscopy | 2009

Pragmatic classification of superficial neoplastic colorectal lesions

René Lambert; Shin Ei Kudo; Michael Vieth; John I. Allen; Hiroaki Fujii; Takahiro Fujii; Hiroshi Kashida; Takahisa Matsuda; Masaki Mori; Hiroshi Saito; Tadakazu Shimoda; Shinji Tanaka; Hidenobu Watanabe; Joseph J. Sung; Andrew D. Feld; John M. Inadomi; Michael J. O'Brien; David A. Lieberman; David F. Ransohoff; Roy M. Soetikno; Ann G. Zauber; Claudio Rolim Teixeira; Jean François Rey; Edgar Jaramillo; Carlos A. Rubio; Andre Van Gossum; Michael Jung; Jeremy R. Jass; George Triadafilopoulos

Recently, the emerging role of nonpolypoid precursors of colorectal cancer has challenged the conventional polyp-cancer sequence. The impact of colonoscopy in cancer prevention depends on its reliability in the diagnosis of colorectal neoplasia when the lesion does not extend beyond the submucosa and is potentially curable. The estimation of the risk of progression is based on the prediction of histology from the morphological appearance of the lesion and includes (1) distinction between neoplastic and non-neoplastic lesions, (2) identification of different categories of non-serrated and serrated lesions, and (3) determination of the localization in the proximal or distal colon, which has an impact on the morphology and behavior of the lesion. The pragmatic classification Of superficial neoplastic lesions proposed in this text takes into account these changes and is based oil a 2-step strategy of endoscopic diagnosis with initial detection and characterization, followed by treatment implementation, Such as endoscopic resection, ablation, and Surgery


Gastrointestinal Endoscopy | 2005

In Vivo Histology of Barrett's Esophagus and Associated Neoplasias By Confocal Laser Endomicroscopy

Ralf Kiesslich; Liebwin Gossner; Alexandra Dahlmann; Michael Vieth; Manfred Stolte; Arthur Hofmann; Michael Jung; Bernhard Nafe; Peter R. Galle; Christian Ell; Markus F. Neurath

BACKGROUND & AIMS Confocal laser endomicroscopy allows subsurface analysis of the intestinal mucosa and in vivo histology during ongoing endoscopy. Here, we have applied this technique to the in vivo diagnosis of Barretts epithelium and associated neoplasia. METHODS Fluorescein-aided endomicroscopy was performed by applying the endomicroscope over the whole columnar-lined lower esophagus. Images obtained within 1 cm of the columnar-lined lower esophagus were stored digitally and a targeted biopsy examination or endoscopic mucosal resection of the examined areas was performed. In vivo histology was compared with the histologic specimens. All digitally stored images were re-assessed by a blinded investigator by the confocal Barrett classification system to predict histology. Intraobserver and interobserver variations of the involved endoscopists were evaluated by using kappa statistics. RESULTS Endomicroscopy allowed distinguishing between different types of epithelial cells and detected cellular and vascular changes in Barretts epithelium at high resolution during ongoing endoscopy in 63 patients. Barretts esophagus and associated neoplasia could be predicted with a sensitivity of 98.1% and 92.9% and a specificity of 94.1% and 98.4%, respectively (accuracy, 96.8% and 97.4%). The mean kappa value for interobserver agreement for the prediction of histopathological diagnosis was .843, whereas the intraobserver agreement showed a mean kappa value of .892. CONCLUSIONS Fluorescence-aided endomicroscopy of Barretts esophagus allows in vivo histology of the mucosal layer during ongoing endoscopy. Gastric and Barretts epithelium and Barretts-associated neoplastic changes can be diagnosed with high accuracy. Thus, endomicroscopy may be helpful in the management of patients with Barretts esophagus.


Endoscopy | 2017

ESGE-ESGENA technical specification for process validation and routine testing of endoscope reprocessing in washer-disinfectors according to EN ISO 15883, parts 1, 4, and ISO/TS 15883-5

U. Beilenhoff; Holger Biering; Reinhard Blum; Jadranka Brljak; Monica Cimbro; Jean-Marc Dumonceau; Cesare Hassan; Michael Jung; C. S. Neumann; Michael Pietsch; Lionel Pineau; Thierry Ponchon; Stanislav Rejchrt; Jean-François Rey; Verona Schmidt; Jayne Tillett; Jeanin E. van Hooft

1 Prerequisites. The clinical service provider should obtain confirmation from the endoscope washer-disinfector (EWD) manufacturer that all endoscopes intended to be used can be reprocessed in the EWD. 2 Installation qualification. This can be performed by different parties but national guidelines should define who has the responsibilities, taking into account legal requirements. 3 Operational qualification. This should include parametric tests to verify that the EWD is working according to its specifications. 4 Performance qualification. Testing of cleaning performance, microbiological testing of routinely used endoscopes, and the quality of the final rinse water should be considered in all local guidelines. The extent of these tests depends on local requirements. According to the results of type testing performed during EWD development, other parameters can be tested if local regulatory authorities accept this. Chemical residues on endoscope surfaces should be searched for, if acceptable test methods are available. 5 Routine inspections. National guidelines should consider both technical and performance criteria. Individual risk analyses performed in the validation and requalification processes are helpful for defining appropriate test frequencies for routine inspections.


Clinical Gastroenterology and Hepatology | 2006

In Vivo Histology of Barrett’s Esophagus and Associated Neoplasia by Confocal Laser Endomicroscopy

Ralf Kiesslich; Liebwin Gossner; Martin Goetz; Alexandra Dahlmann; Michael Vieth; Manfred Stolte; Arthur Hoffman; Michael Jung; Bernhard Nafe; Peter R. Galle; Markus F. Neurath


Gastrointestinal Endoscopy | 2008

Nonpolypoid neoplastic lesions of the colorectal mucosa.

Shin Ei Kudo; René Lambert; John I. Allen; Hiroaki Fujii; Takahiro Fujii; Hiroshi Kashida; Takahisa Matsuda; Masaki Mori; Hiroshi Saito; Tadakazu Shimoda; Shinji Tanaka; Hidenobu Watanabe; Joseph J. Sung; Andrew D. Feld; John M. Inadomi; Michael J. O'Brien; David A. Lieberman; David F. Ransohoff; Roy Soetikno; George Triadafilopoulos; Ann G. Zauber; Claudio Rolim Teixeira; Jean François Rey; Edgar Jaramillo; Carlos A. Rubio; Andre Van Gossum; Michael Jung; Michael Vieth; Jeremy R. Jass; Paul D. Hurlstone


Gastrointestinal Endoscopy | 2006

Acetic acid–guided biopsies after magnifying endoscopy compared with random biopsies in the detection of Barrett's esophagus: a prospective randomized trial with crossover design

Arthur Hoffman; Ralf Kiesslich; Andreas Bender; Markus F. Neurath; Bernhard Nafe; Günter Herrmann; Michael Jung


Endoscopy | 2003

Standardized reprocessing of reusable colonoscopy biopsy forceps is effective: Results of a German multicenter study

Michael Jung; U. Beilenhoff; Michael Pietsch; B. Kraft; G. Rippin


Endoscopy | 2017

Prevention of multidrug-resistant infections from contaminated duodenoscopes: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA)

U. Beilenhoff; Holger Biering; Reinhard Blum; Jadranka Brljak; Monica Cimbro; Jean-Marc Dumonceau; Cesare Hassan; Michael Jung; C. S. Neumann; Michael Pietsch; Lionel Pineau; Thierry Ponchon; Stanislav Rejchrt; Jean-François Rey; Verona Schmidt; Jayne Tillett; Jeanin E. van Hooft


/data/revues/00165107/v63i5/S0016510706008388/ | 2011

Acetic Acid Guided Biopsies After Magnifying Endoscopy Compared with Random Biopsies in the Detection of Barrett`s Esophagus a Prospective Randomized Trial with Cross Over Design

Arthur Hoffman; Ralf Kiesslich; Andreas Bender; Markus F Neurath; Bernhard Nafe; Günter Herrmann; Michael Jung


Endoscopy | 2002

Reply to the Letter of Orlowska et al.

Ralf Kiesslich; G. Herrmann; Michael Jung

Collaboration


Dive into the Michael Jung's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Markus F. Neurath

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

Andre Van Gossum

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Andrew D. Feld

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Claudio Rolim Teixeira

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

David A. Lieberman

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

David F. Ransohoff

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Edgar Jaramillo

International Agency for Research on Cancer

View shared research outputs
Researchain Logo
Decentralizing Knowledge